摘要 |
The invention relates to a use of a first substance which at least partly blocks specific receptors for a given neurotransmitter post-synaptically and a second substance which initiates or promotes a deafferentation of the innervation related to the neurotransmitter, for the treatment of Parkinsons disease, the production of a pharmaceutical for the treatment of Parkinsons disease, or a pharmaceutical combination for the treatment of Parkinsons disease. The invention further relates to a pharmaceutical combination. |